Table 1 Experiment 1 (antitumor effect)
From: Using water-soluble C60 fullerenes in anticancer therapy
Number of days after tumor transplantation | Group 0 (control) | Group 1 (injection of C60FAS before tumor transplantation) | Tumor growth inhibition*, | Group 2 (injection of C60FAS after tumor transplantation) | Tumor growth inhibition*, |
|---|---|---|---|---|---|
15 | n = 5 | n = 5 | 17.0 | n = 5 | 30.0 |
18 | n = 5 | n = 5 | 4.0 | n = 5 | 37.2 |
20 | n = 5 | n = 4 | 13.0 | n = 5 | 19.4 |
22 | n = 4 | n = 4 | 11.3 | n = 5 | 13.6 |
25 | n = 3 | n = 3 | 3.1 | n = 4 | 16.0 |
27 | n = 2 | n = 2 | n = 2 | ||
32 | n = 0 | n = 1 | n = 2 | ||
35 | n = 1 | n = 1 | |||
39 | n = 0 | n = 0 |
, %
, %
- Start of C60FAS injection before the tumor transplantation—12 October 2010 (group 1; protective effect). Start of tumor transplantation—22 October 2010. Start of C60FAS injection after the tumor transplantation—24 October 2010 (group 2; inhibitive effect). Initial number of animals in experimental groups was n = 5. Survival of animals (
, percent) is given in parentheses - *p < 0.05, the differences are statistically valid compared with the control
, percent) is given in parentheses